BioInvent and Transgene and report positive BT-001 data

Tumour treatment among all phase 1a cohorts in were concluded with no safety concerns - News - PharmaTimes

Related Keywords

Martin Welschof ,Bioinvent International ,Bioinvent ,Transgene ,T 001 ,